{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:25:00Z","timestamp":1781321100308,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014218","name":"Nanjing Military Region Medical Scientific and Technical Innovation Foundation Projects of People\u2019s Liberation Army of China","doi-asserted-by":"publisher","award":["2015MS088"],"award-info":[{"award-number":["2015MS088"]}],"id":[{"id":"10.13039\/501100014218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recombinant human Interleukin receptor antagonist (rhIL-Ra) can bind to the IL-1 receptor on the cell membrane and reversibly blocks the proinflammatory signaling pathway. However, its effect on allergic rhinitis (AR) and the underlying mechanism remains unknown. This study aims to investigate the efficacy of recombinant human interleukin-1 receptor antagonist (rhIL-1Ra) on AR guinea pigs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Guinea pigs were systemically sensitized by intraperitoneal injection and topical intranasal instillation with ovalbumin within 21 days. Animals administrated with saline served as the normal control. The AR animals were randomly divided into the model group and distinct concentrations of rhIL-1Ra and budesonide treatment groups. IL-1\u03b2 and ovalbumin specific IgE levels were detected by ELISA kits. Nasal mucosa tissues were stained with hematoxylin &amp; eosin (HE) for histological examination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>It was found that the numbers of sneezing and nose rubbing were remarkably reduced in rhIL-1Ra and budesonide-treated guinea pigs. Besides, rhIL-1Ra distinctly alleviated IgE levels in serum and IL-1\u03b2 levels in nasal mucus, together with decreased exfoliation of epithelial cells, eosinophilic infiltration, tissue edema and vascular dilatation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>rhIL-1Ra is effective in AR guinea pigs and may provide a novel potential choice for AR treatments.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13223-024-00893-9","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T05:05:56Z","timestamp":1717477556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic potential of the topical recombinant human interleukin-1 receptor antagonist in guinea pigs with allergic rhinitis"],"prefix":"10.1186","volume":"20","author":[{"given":"Haibing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanjuan","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexia","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"893_CR1","doi-asserted-by":"publisher","first-page":"104496","DOI":"10.1016\/j.fitote.2020.104496","volume":"144","author":"C Jin","year":"2020","unstructured":"Jin C, Ye K, Luan H, Liu L, Zhang R, Yang S, et al. Tussilagone inhibits allergic responses in OVA-induced allergic rhinitis guinea pigs and IgE-stimulated RBL-2H3 cells. Fitoterapia. 2020;144:104496.","journal-title":"Fitoterapia"},{"issue":"12","key":"893_CR2","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1017\/S1092852900017089","volume":"13","author":"SM Stahl","year":"2008","unstructured":"Stahl SM. Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines. CNS Spectr. 2008;13(12):1027\u201338.","journal-title":"CNS Spectr"},{"issue":"3","key":"893_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2174\/1871523011202030230","volume":"11","author":"F Kalpaklioglu","year":"2012","unstructured":"Kalpaklioglu F, Baccioglu A. Efficacy and safety of H1-antihistamines: an update. Antiinflamm Antiallergy Agents Med Chem. 2012;11(3):230\u20137.","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"issue":"11","key":"893_CR4","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1258\/002221503322542818","volume":"117","author":"AN Waddell","year":"2003","unstructured":"Waddell AN, Patel SK, Toma AG, Maw AR. Intranasal steroid sprays in the treatment of rhinitis: is one better than another? J Laryngol Otol. 2003;117(11):843\u20135.","journal-title":"J Laryngol Otol"},{"key":"893_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13223-020-00436-y","volume":"16","author":"L Hossenbaccus","year":"2020","unstructured":"Hossenbaccus L, Linton S, Garvey S, Ellis AK. Towards definitive management of allergic rhinitis: best use of new and established therapies. Allergy Asthma Clin Immunol. 2020;16:39.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"893_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fimmu.2019.00250","volume":"10","author":"PG Ritvo","year":"2019","unstructured":"Ritvo PG, Klatzmann D. Interleukin-1 in the response of follicular helper and follicular regulatory T cells. Front Immunol. 2019;10:250.","journal-title":"Front Immunol"},{"issue":"5","key":"893_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/art.1780370507","volume":"37","author":"GS Firestein","year":"1994","unstructured":"Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, et al. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum. 1994;37(5):644\u201352.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"893_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0165-5728(95)00108-E","volume":"61","author":"D Martin","year":"1995","unstructured":"Martin D, Near SL. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats. J Neuroimmunol. 1995;61(2):241\u20135.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"893_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/CAD.0000000000000142","volume":"26","author":"X Wang","year":"2015","unstructured":"Wang X, Gao J, Qian L, Gao J, Zhu S, Wu M, et al. Exogenous IL-1Ra attenuates intestinal mucositis induced by oxaliplatin and 5-fluorouracil through suppression of p53-dependent apoptosis. Anticancer Drugs. 2015;26(1):35\u201345.","journal-title":"Anticancer Drugs"},{"issue":"7","key":"893_CR10","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/art.40865","volume":"71","author":"NM Ter Haar","year":"2019","unstructured":"Ter Haar NM, van Dijkhuizen EHP, Swart JF, van Royen-Kerkhof A, El Idrissi A, Leek AP, et al. Treatment to target using recombinant interleukin-1 receptor antagonist as first-line monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five-year follow-up study. Arthritis Rheumatol. 2019;71(7):1163\u201373.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"893_CR11","first-page":"555","volume":"4","author":"E Oelmann","year":"1994","unstructured":"Oelmann E, Topp M, Reufi B, Papadimitriou C, Koenigsmann M, Oberberg D, et al. Interleukin-1 receptor antagonist inhibits growth modulation of human tumor-cell lines by interleukin-1 in-vitro. Int J Oncol. 1994;4(3):555\u20138.","journal-title":"Int J Oncol"},{"issue":"3","key":"893_CR12","first-page":"908","volume":"43","author":"Y Chen","year":"2020","unstructured":"Chen Y, Yang Z, Deng B, Wu D, Quan Y, Min Z. Interleukin 1beta\/1RA axis in colorectal cancer regulates tumor invasion, proliferation and apoptosis via autophagy. Oncol Rep. 2020;43(3):908\u201318.","journal-title":"Oncol Rep"},{"issue":"10","key":"893_CR13","first-page":"1115","volume":"39","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Xiao X, Yang Z, Zhou M, Chen H, Yuan Y. Protective effect of recombinant human IL-1Ra on hepatocytes in vitro. J Shanghai Jiaotong Univ (Medical Science). 2019;39(10):1115\u201321.","journal-title":"J Shanghai Jiaotong Univ (Medical Science)"},{"issue":"12","key":"893_CR14","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1183\/109031936.95.08122104","volume":"8","author":"S Underwood","year":"1995","unstructured":"Underwood S, Foster M, Raeburn D, Bottoms S, Karlsson JA. Time-course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness. Eur Respir J. 1995;8(12):2104\u201313.","journal-title":"Eur Respir J"},{"issue":"11","key":"893_CR15","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.intimp.2008.06.010","volume":"8","author":"PC Bahekar","year":"2008","unstructured":"Bahekar PC, Shah JH, Ayer UB, Mandhane SN, Thennati R. Validation of guinea pig model of allergic rhinitis by oral and topical drugs. Int Immunopharmacol. 2008;8(11):1540\u201351.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"893_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.33549\/physiolres.930840","volume":"55","author":"M Brozmanova","year":"2006","unstructured":"Brozmanova M, Calkovsky V, Plevkova J, Bartos V, Plank L, Tatar M. Early and late allergic phase related cough response in sensitized guinea pigs with experimental allergic rhinitis. Physiol Res. 2006;55(5):577\u201384.","journal-title":"Physiol Res"},{"issue":"1","key":"893_CR17","first-page":"23","volume":"14","author":"H Xiao","year":"2012","unstructured":"Xiao H, Xie Y, Li B, Li H, Di C, Hu M, et al. Establishment and characteristics of a TDI-induced model of allergic rhinitis in guinea pigs. Military Med J Southeast China. 2012;14(1):23\u20136.","journal-title":"Military Med J Southeast China"},{"issue":"2","key":"893_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.vascn.2006.05.005","volume":"55","author":"M Al Suleimani","year":"2007","unstructured":"Al Suleimani M, Ying D, Walker MJ. A comprehensive model of allergic rhinitis in guinea pigs. J Pharmacol Toxicol Methods. 2007;55(2):127\u201334.","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"3","key":"893_CR19","first-page":"251","volume":"24","author":"HQ Zhang","year":"2003","unstructured":"Zhang HQ, Sun Y, Xu F. Therapeutic effects of interleukin-1 receptor antagonist on allergic rhinitis of guinea pig. Acta Pharmacol Sin. 2003;24(3):251\u20135.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"893_CR20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1159\/000234540","volume":"85","author":"K Tanaka","year":"1988","unstructured":"Tanaka K, Okamoto Y, Nagaya Y, Nishimura F, Takeoka A, Hanada S, et al. A nasal allergy model developed in the guinea pig by intranasal application of 2,4-toluene diisocyanate. Int Arch Allergy Appl Immunol. 1988;85(4):392\u20137.","journal-title":"Int Arch Allergy Appl Immunol"},{"issue":"14","key":"893_CR21","doi-asserted-by":"publisher","first-page":"18423","DOI":"10.18632\/aging.203292","volume":"13","author":"Z Yan","year":"2021","unstructured":"Yan Z, Liu L, Yuan J, Jiao L, Zhou M, Liu J, et al. Yiqi Jiemin decoction alleviates allergic rhinitis in a guinea pig model by suppressing inflammation, restoring Th1\/Th2 balance, and improving cellular metabolism. Aging. 2021;13(14):18423\u201341.","journal-title":"Aging"},{"key":"893_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.intimp.2019.05.021","volume":"73","author":"H Tang","year":"2019","unstructured":"Tang H, Li T, Han X, Sun J. TLR4 antagonist ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing inflammatory monocytes infiltration in mice model. Int Immunopharmacol. 2019;73:254\u201360.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"893_CR23","first-page":"4097","volume":"23","author":"YQ Zhu","year":"2019","unstructured":"Zhu YQ, Liao B, Liu YH, Wang Z, Zhu XH, Chen XB, et al. MicroRNA-155 plays critical effects on Th2 factors expression and allergic inflammatory response in type-2 innate lymphoid cells in allergic rhinitis. Eur Rev Med Pharmacol Sci. 2019;23(10):4097\u2013109.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"893_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12950-020-0236-9","volume":"17","author":"W Tu","year":"2020","unstructured":"Tu W, Chen X, Wu Q, Ying X, He R, Lou X, et al. Acupoint application inhibits nerve growth factor and attenuates allergic inflammation in allergic rhinitis model rats. J Inflamm (Lond). 2020;17:4.","journal-title":"J Inflamm (Lond)"},{"issue":"4","key":"893_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11882-018-0781-y","volume":"18","author":"JB Morjaria","year":"2018","unstructured":"Morjaria JB, Caruso M, Emma R, Russo C, Polosa R. Treatment of allergic rhinitis as a strategy for preventing asthma. Curr Allergy Asthma Rep. 2018;18(4):23.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"893_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/ijms20010213","volume":"20","author":"H Kawauchi","year":"2019","unstructured":"Kawauchi H, Yanai K, Wang DY, Itahashi K, Okubo K. Antihistamines for allergic rhinitis treatment from the viewpoint of nonsedative properties. Int J Mol Sci. 2019;20(1):213.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"893_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.pharmthera.2007.01.012","volume":"114","author":"YM Al Suleimani","year":"2007","unstructured":"Al Suleimani YM, Walker MJ. Allergic rhinitis and its pharmacology. Pharmacol Ther. 2007;114(3):233\u201360.","journal-title":"Pharmacol Ther"},{"issue":"2 Pt 1","key":"893_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0091-6749(00)90068-X","volume":"105","author":"P Christodoulopoulos","year":"2000","unstructured":"Christodoulopoulos P, Cameron L, Durham S, Hamid Q. Molecular pathology of allergic disease. II: Upper airway disease. J Allergy Clin Immunol. 2000;105(2 Pt 1):211\u201323.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"893_CR29","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/aps.2013.88","volume":"34","author":"SH He","year":"2013","unstructured":"He SH, Zhang HY, Zeng XN, Chen D, Yang PC. Mast cells and basophils are essential for allergies: mechanisms of allergic inflammation and a proposed procedure for diagnosis. Acta Pharmacol Sin. 2013;34(10):1270\u201383.","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"893_CR30","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000500088","volume":"179","author":"G Varricchi","year":"2019","unstructured":"Varricchi G, Rossi FW, Galdiero MR, Granata F, Criscuolo G, Spadaro G, et al. Physiological roles of mast cells: collegium internationale allergologicum update 2019. Int Arch Allergy Immunol. 2019;179(4):247\u201361.","journal-title":"Int Arch Allergy Immunol"},{"issue":"2","key":"893_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/iub.2568","volume":"74","author":"YR Wu","year":"2022","unstructured":"Wu YR, Hsing CH, Chiu CJ, Huang HY, Hsu YH. Roles of IL-1 and IL-10 family cytokines in the progression of systemic lupus erythematosus: friends or foes? IUBMB Life. 2022;74(2):143\u201356.","journal-title":"IUBMB Life"},{"issue":"1","key":"893_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/imr.12606","volume":"281","author":"D Boraschi","year":"2018","unstructured":"Boraschi D, Italiani P, Weil S, Martin MU. The family of the interleukin-1 receptors. Immunol Rev. 2018;281(1):197\u2013232.","journal-title":"Immunol Rev"},{"key":"893_CR33","volume-title":"Identification and testing of recombinant human interleukin-1 receptor antagonist","author":"C Wang","year":"2013","unstructured":"Wang C. Identification and testing of recombinant human interleukin-1 receptor antagonist. China National Knowledge Internet: Jilin Agricultural University; 2013."},{"issue":"2","key":"893_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1067\/mai.2000.108111","volume":"106","author":"M Benson","year":"2000","unstructured":"Benson M, Strannegard IL, Strannegard O, Wennergren G. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils. J Allergy Clin Immunol. 2000;106(2):307\u201312.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"893_CR35","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1159\/000511532","volume":"182","author":"HC Yang","year":"2021","unstructured":"Yang HC, Won EJ, Kim MJ, Sung CM, Rhee JH, Nam KI. Intralymphatic administration of metagonimus yokogawai-extracted protein attenuates experimental murine allergic rhinitis model. Int Arch Allergy Immunol. 2021;182(5):381\u20137.","journal-title":"Int Arch Allergy Immunol"},{"issue":"12","key":"893_CR36","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00011-016-0979-1","volume":"65","author":"HY Kim","year":"2016","unstructured":"Kim HY, Nam SY, Jang JB, Choi Y, Kang IC, Kim HM, et al. 2-(4-2-[(phenylthio)acetyl]carbonohydrazonoylphenoxy)acetamide as a new lead compound for management of allergic rhinitis. Inflamm Res. 2016;65(12):963\u201373.","journal-title":"Inflamm Res"},{"issue":"2","key":"893_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2332\/allergolint.10-RAI-0190","volume":"59","author":"A Nambu","year":"2010","unstructured":"Nambu A, Nakae S. IL-1 and allergy. Allergol Int. 2010;59(2):125\u201335.","journal-title":"Allergol Int"},{"issue":"5","key":"893_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nm.2755","volume":"18","author":"SJ Galli","year":"2012","unstructured":"Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18(5):693\u2013704.","journal-title":"Nat Med"},{"key":"893_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13223-019-0368-8","volume":"15","author":"MW Han","year":"2019","unstructured":"Han MW, Kim SH, Oh I, Kim YH, Lee J. Serum IL-1beta can be a biomarker in children with severe persistent allergic rhinitis. Allergy Asthma Clin Immunol. 2019;15:58.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"3","key":"893_CR40","first-page":"3193","volume":"16","author":"Q Shi","year":"2018","unstructured":"Shi Q, Lei Z, Cheng G, Li D, Wang Q, Luo S, et al. Mitochondrial ROS activate interleukin-1beta expression in allergic rhinitis. Oncol Lett. 2018;16(3):3193\u2013200.","journal-title":"Oncol Lett"},{"issue":"6256","key":"893_CR41","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/343336a0","volume":"343","author":"CH Hannum","year":"1990","unstructured":"Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990;343(6256):336\u201340.","journal-title":"Nature"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-024-00893-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-024-00893-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-024-00893-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T06:04:27Z","timestamp":1717481067000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-024-00893-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["893"],"URL":"https:\/\/doi.org\/10.1186\/s13223-024-00893-9","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"3 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiment was approved by the Ethics Committee of Beijing Institute of Radiation Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}